Raltegravir (MK-0518)
Catalog No. A10775
Raltegravir (MK-0518)靶向整合酶,这是一种HIV酶,可将病毒遗传物质整合到人类染色体中,这是HIV发病机理中的关键步骤。
- Michal S Barski, .et al. Structural basis for the inhibition of HTLV-1 integration inferred from cryo-EM deltaretroviral intasome structures, Nat Commun, 2021, Aug 17;12(1):4996 PMID: 34404793
- Lea El Khoury, .et al. Spectrometric and computational studies of the binding of HIV-1 integrase inhibitors to viral DNA extremities, PeerJ Preprints, 2019, 7:e27833v1
Catalog Num | A10775 |
---|---|
M. Wt | 444.4 |
Formula | C20H21FN6O5 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 518048-05-0 |
Synonyms | Isentress, MK0518, MK-0518 |
SMILES | CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)[O-])C(=O)NCC3=CC=C(C=C3)F.[K+] |
Raltegravir (MK-0518)靶向整合酶,这是一种HIV酶,可将病毒遗传物质整合到人类染色体中,这是HIV发病机理中的关键步骤。
In vitro (25°C) | DMSO | 80 mg/mL (180.01 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 2% DMSO+40% PEG 300+2% Tween 80+ddH2O | 7 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.5 mL | 112.51 mL | 225.02 mL |
0.5 mM | 4.5 mL | 22.5 mL | 45 mL |
1 mM | 2.25 mL | 11.25 mL | 22.5 mL |
5 mM | 0.45 mL | 2.25 mL | 4.5 mL |
*The above data is based on the productmolecular weight 444.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.